JPRN-UMIN000008710招募中未知
Randomized phase II study comparing pegylated interferon alpha-2b combined with intra-arterial 5-fluorouracil and sorafenib alone for advanced hepatocellular carcinoma - Comparing pegylated interferon alpha-2b combined with 5-fluorouracil and sorafenib for advanced hepatocellular carcinoma
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria for treatment were as follows:1) pregnancy women 2) patients who had allergic disorder and severe disease
研究者
相似试验
已完成
2 期
Gemcitabine with the standard dose (1000 mg/m2) is equal to low dose (250 mg/m2) with just prolongation of the infusion time in Patients with Advanced Pancreatic cancerCancerPACTR201901862142418South Egypt cancer Institute100
已完成
2 期
Oral drug therapy as palliative chemotherapy in Head and Neck cancersCTRI/2014/07/004791Tata Memorial Hospital110
尚未招募
2 期
A clinical trial comparing pulmonary complications in two routes of gastric conduit placement after esophagectomyCTRI/2024/02/062245AIIMS NEW DELHI
已完成
2 期
A phase II randomized controlled trial comparing perioperative mFOLFOXIRI with perioperative chemoradiotherapy for locally advanced rectal cancer.Rectal cancerJPRN-UMIN000018624Osaka Medical College Hospital34
招募中
2 期
A randomized controlled phase 2 trial comparing the safety and usefulness of robot-assisted esophagectomy and thoracoscopicJPRN-jRCT1040220153Takeuchi Hiroya90